Related references
Note: Only part of the references are listed.A Randomized, Placebo-Controlled, Respiratory Syncytial Virus Human Challenge Study of the Antiviral Efficacy, Safety, and Pharmacokinetics of RV521, an Inhibitor of the RSV-F Protein
John DeVincenzo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Minimal Elements Required for the Formation of Respiratory Syncytial Virus Cytoplasmic Inclusion Bodies In Vivo and In Vitro
Marie Galloux et al.
MBIO (2020)
Polymerase-tagged respiratory syncytial virus reveals a dynamic rearrangement of the ribonucleocapsid complex during infection
Emmeline L. Blanchard et al.
PLOS PATHOGENS (2020)
Advances in respiratory virus therapeutics - A meeting report from the 6th for isirv Antiviral Group conference
John H. Beigel et al.
ANTIVIRAL RESEARCH (2019)
Discovery of Ziresovir as a Potent, Selective, and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein Inhibitor
Xiufang Zheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study
Olga Chatzis et al.
BMC INFECTIOUS DISEASES (2018)
Late therapeutic intervention with a respiratory syncytial virus L-protein polymerase inhibitor, PC786, on respiratory syncytial virus infection in human airway epithelium
Daniel W. Brookes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Antiviral Activity of Oral JNJ-53718678 in Healthy Adult Volunteers Challenged With Respiratory Syncytial Virus: A Placebo-Controlled Study
Marita Stevens et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
Ting Shi et al.
LANCET (2017)
ViroSpot microneutralization assay for antigenic characterization of human influenza viruses
Carel A. van Baalen et al.
VACCINE (2017)
Functional organization of cytoplasmic inclusion bodies in cells infected by respiratory syncytial virus
Vincent Rincheval et al.
NATURE COMMUNICATIONS (2017)
Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series
Nienke M. Scheltema et al.
LANCET GLOBAL HEALTH (2017)
Ribavirin: Past, present and future
Veronique Loustaud-Ratti et al.
WORLD JOURNAL OF HEPATOLOGY (2016)
Oral ribavirin for respiratory syncytial virus infection after lung transplantation: Efficacy and cost-efficiency
Fay S. Burrows et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2015)
Discovery of an Oral Respiratory Syncytial Virus (RSV) Fusion Inhibitor (GS-5806) and Clinical Proof of Concept in a Human RSV Challenge Study
Richard L. Mackman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Discovery of 4′-Chloromethyl-2′-deoxy-3′,5′-di-O-isobutyryl-2′-fluorocytidine (ALS-8176), A First-in-Class RSV Polymerase Inhibitor for Treatment of Human Respiratory Syncytial Virus Infection
Guangyi Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
A Druggable Pocket at the Nucleocapsid/Phosphoprotein Interaction Site of Human Respiratory Syncytial Virus
Mohamed Ouizougun-Oubari et al.
JOURNAL OF VIROLOGY (2015)
Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study
John P. DeVincenzo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2′-Fluoro-4′-Chloromethyl-Cytidine Triphosphate
Jerome Deval et al.
PLOS PATHOGENS (2015)
Mechanism of Action for Respiratory Syncytial Virus Inhibitor RSV604
SreeRupa Challa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Antiviral Activity of TMC353121, a Respiratory Syncytial Virus (RSV) Fusion Inhibitor, in a Non-Human Primate Model
Gabriela Ispas et al.
PLOS ONE (2015)
Characterization of a Respiratory Syncytial Virus L Protein Inhibitor
Choi-Lai Tiong-Yip et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Discovery of a potent respiratory syncytial virus RNA polymerase inhibitor
Hui Xiong et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis
Harish Nair et al.
LANCET (2013)
Characterization of a Viral Phosphoprotein Binding Site on the Surface of the Respiratory Syncytial Nucleoprotein
Marie Galloux et al.
JOURNAL OF VIROLOGY (2012)
Respiratory Syncytial Virus-associated Hospitalizations Among Infants and Young Children in the United States, 1997-2006
Lauren J. Stockman et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
RSV604, a novel inhibitor of respiratory syncytial virus replication
Joanna Chapman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
1,4-Benzodiazepines as inhibitors of respiratory syncytial virus
MC Carter et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Respiratory syncytial virus infection in elderly and high-risk adults
AR Falsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A simplified plaque assay for respiratory syncytial virus - direct visualization of plaques without immunostaining
JL McKimm-Breschkin
JOURNAL OF VIROLOGICAL METHODS (2004)
Share Paper
